Jan 26, 2021
Beyond the Guidelines: Clinical Investigator Perspectives on the
Management of Triple-Negative Breast Cancer — Faculty Presentation
4: Current and Future Role of PARP Inhibitors for Patients with
TNBC and a BRCA Mutation — Dr Marcom.
CME information and select publications